🇮🇳 "3D" regimen in India

"3D" regimen ("3D" regimen) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

"3D" regimen in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is "3D" regimen approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for "3D" regimen in India?

Kirby Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.